Read More Apparatus Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Nov 13, 2024
Read More Apparatus New CAR-T Therapy CB-010, Granted Two FDA Designations And Three Patients Are Cancer-Free For Six Months! Nov 12, 2024
Read More Medical Cabozantinib In Combination With Atelizumab Works Well For Advanced Head And Neck Cancer Nov 12, 2024
